Pharmaceutical Marketing News

The first week in May brought a new leader in France and new prospects for same sex couples seeking marriage.

In over a decade online, this is the first time DV has asked for donations. Please help DV continue its effort in the struggle for peace and social justice.

PhRMA is itching to challenge FDA's authority to regulate DTC advertising in front of the Supreme Court, arguing that recent "Draft FDA Guidance on PreDissemination Review of TV Direct-to-Consumer Ads" violates the Free Speech Clause of the First Amendment because pharmaceutical marketing is a form of free speech .

In a 20-page comment submitted to the FDA on May 14, 2012, the Pharmaceutical Research and Manufacturers of America , advised the FDA to "proceed cautiously and in a manner that fully protects the free speech rights of advertisers and patients" with regard to the agency's recent Draft Guidance for Industry on Direct-to-Consumer Television ... (more)

This week, the U.S. Food and Drug Administration will consider allowing an anti-HIV drug to be promoted to otherwise healthy, HIV-free people as a purely preventative measure for the first time.

"We live in an environment of continuous change and unlimited access to knowledge.

Marketing services group Cello has said that it plans to continue to invest in overseas pharmaceutical activity, particularly within the US.

Stockholm Medivir AB , a research-based specialty pharmaceutical company focused on infectious diseases, announced today that it has appointed Henric Juserius to be the new head of the company's commercial activities.

PharmedOut, a Georgetown University Medical Center-based pharmaceutical marketing research project, hosts its highly-acclaimed third annual conference focusing on the misinformation and patient harm that can occur from pharmaceutical and medical device marketing.

The free market is alive and well when it comes to drug prices - if you're an insurance company or a government program.

Despite Pfizer's heroic and unprecedented effort to maintain Lipitor's market share after expiry last November and after spending "more than $87 million promoting the medicine, the world's biggest drug company is quietly giving up on its once-great cash cow for good because more generic versions will soon be going on sale" . As I reported here on ... (more)

Bloomberg News LIBERTYVILLE TOWNSHIP -- Abbott Laboratories said it will pay $1.6 billion to settle federal and state claims resulting from an investigation into its neurologic medication Depakote.

Are you ever worried that you have mental problems that require professional attention? If not, then maybe you should be.